Current Protocols in Human Genetics

Overview

Individual Online Subscriptions are now available! Visit the How to Order page for more information.

What's New in Current Protocols in Human Genetics
Supplement 77, April 2013

Unit 1.24 Methods for Meta-Analysis of Genetic Data
         Abstract | Full Text:  HTML   PDF

Unit 9.22 Whole Genome Sequencing: A Considered Approach to Clinical Implementation
         Abstract | Full Text:  HTML   PDF

Unit 9.23 Management of Incidental Findings in Clinical Genomic Sequencing
         Abstract | Full Text:  HTML   PDF

Unit 17.13 Diagnosing Lysosomal Storage Disorders: Fabry Disease
         Abstract | Full Text:  HTML   PDF

Unit 20.2 Analysis of Epigenetic Modifications of DNA in Human Cells
         Abstract | Full Text:  HTML   PDF

Current Protocols in Human Genetics is the resource for designing and running successful research projects in all branches of human genetics.

Updated every three months in all formats, CPHG is constantly evolving to keep pace with the very latest discoveries and developments. A year of these quarterly updates is included in the initial CPHG purchase price. That's 570 pages of new (43%) and revised (57%) content on average every year since the initial publication of the work in April 1994! Presently four volumes in its looseleaf print version, CPHG...

• features methods in all areas of genetic research, including disease study, expression analysis, clinical genetics, analysis of sequence variants, cytogenetics, gene therapy, forensic genetics, biochemical genetics and more.
• offers basic to sophisticated methods— many of them equally applicable to other eukaryotic organisms, such as the mouse.
• provides valuable appendices, such as "Commonly Used Techniques" which includes molecular biology and cell culture methods, basic mouse handling techniques, basic statistics.

Edited by: Jonathan L. Haines (Vanderbilt University Medical Center); Bruce R. Korf (University of Alabama at Birmingham); Cynthia C. Morton (Brigham and Women's Hospital and Harvard Medical School); Christine E. Seidman (Brigham and Women's Hospital and Harvard Medical School); J.G. Seidman (Harvard Medical School); Douglas R. Smith (Beckman Coulter Genomics); Guest Editors: J. Daniel Sharer (University of Alabama at Birmingham); Theresa V. Strong (University of Alabama at Birmingham); Past Editors: Nicholas C. Dracopoli (Bristol-Myers Squibb); Donald T. Moir (Microbiotix, Inc.); Anthony Rosenzweig (Beth Israel Deaconess Medical Center and Harvard Medical School)

Developmental Editor: Ann Boyle

While the authors, editors, and publisher believe that the specification and usage of reagents, equipment, and devices, as set forth in this book, are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained herein. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of experimental reagents, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each chemical, piece of equipment, reagent, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. This is particularly important in regard to new or infrequently employed chemicals or experimental reagents. Moreover, the information presented herein is not a substitute for professional judgment, especially as concerns any applications in a clinical setting or the interpretation of results thereby obtained.